Loading...
Glass House Brands Inc.
GLASF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$5.51
$0.23(4.36%)
Glass House Brands Inc. (GLASF) Financial Performance & Income Statement Overview
Review Glass House Brands Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
24.91%
↑ 24.91%
Operating Income Growth
111.58%
↑ 111.58%
Net Income Growth
100.53%
↑ 100.53%
Operating Cash Flow Growth
22.25%
↑ 22.25%
Operating Margin
5.33%
↑ 5.33%
Gross Margin
46.94%
↑ 46.94%
Net Profit Margin
4.08%
↑ 4.08%
ROE
6.68%
↑ 6.68%
ROIC
4.20%
↑ 4.20%
Glass House Brands Inc. (GLASF) Income Statement & Financial Overview
Review Glass House Brands Inc.'s (GLASF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $53.04M | $63.82M | $53.93M | $29.97M |
| Cost of Revenue | $30.29M | $30.38M | $28.98M | $21.19M |
| Gross Profit | $22.75M | $33.44M | $24.95M | $8.77M |
| Gross Profit Ratio | $0.43 | $0.52 | $0.46 | $0.29 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $16.80M | $15.94M | $19.90M | $17.59M |
| Operating Expenses | $20.68M | $25.97M | $19.90M | $17.59M |
| Total Costs & Expenses | $50.96M | $56.34M | $48.90M | $38.78M |
| Interest Income | $0.00 | $0.00 | $0.00 | $34.00 |
| Interest Expense | $2.13M | $2.25M | $2.59M | $2.21M |
| Depreciation & Amortization | $3.87M | $3.73M | $3.72M | $3.70M |
| EBITDA | $18.69M | $11.71M | $8.77M | -$11.46M |
| EBITDA Ratio | $0.35 | $0.18 | $0.16 | -$0.38 |
| Operating Income | $2.08M | $7.48M | $5.04M | -$8.82M |
| Operating Income Ratio | $0.04 | $0.12 | $0.09 | -$0.29 |
| Other Income/Expenses (Net) | $10.61M | -$1.75M | $5.20M | -$8.58M |
| Income Before Tax | $12.69M | $5.73M | $10.24M | -$17.36M |
| Income Before Tax Ratio | $0.24 | $0.09 | $0.19 | -$0.58 |
| Income Tax Expense | $526000.00 | $8.94M | $202958.00 | $830527.00 |
| Net Income | $12.10M | -$3.25M | $10.00M | -$18.25M |
| Net Income Ratio | $0.23 | -$0.05 | $0.19 | -$0.61 |
| EPS | $0.10 | -$0.09 | $0.08 | -$0.25 |
| Diluted EPS | $0.10 | -$0.09 | $0.08 | -$0.25 |
| Weighted Avg Shares Outstanding | $76.60M | $75.96M | $73.81M | $73.16M |
| Weighted Avg Shares Outstanding (Diluted) | $76.60M | $75.96M | $82.23M | $73.16M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan